JP2023544822A - I型crispr関連トランスポザーゼシステム - Google Patents

I型crispr関連トランスポザーゼシステム Download PDF

Info

Publication number
JP2023544822A
JP2023544822A JP2023521484A JP2023521484A JP2023544822A JP 2023544822 A JP2023544822 A JP 2023544822A JP 2023521484 A JP2023521484 A JP 2023521484A JP 2023521484 A JP2023521484 A JP 2023521484A JP 2023544822 A JP2023544822 A JP 2023544822A
Authority
JP
Japan
Prior art keywords
cell
sequence
composition
polynucleotide
cas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023521484A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544822A5 (https=
JPWO2022076830A5 (https=
Inventor
フェン チャン
諒 齋藤
ジョナサン ストレッカー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Broad Institute Inc
Original Assignee
Massachusetts Institute of Technology
Broad Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology, Broad Institute Inc filed Critical Massachusetts Institute of Technology
Publication of JP2023544822A publication Critical patent/JP2023544822A/ja
Publication of JP2023544822A5 publication Critical patent/JP2023544822A5/ja
Publication of JPWO2022076830A5 publication Critical patent/JPWO2022076830A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/80Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/90Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Automatic Cycles, And Cycles In General (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2023521484A 2020-10-08 2021-10-08 I型crispr関連トランスポザーゼシステム Pending JP2023544822A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063089220P 2020-10-08 2020-10-08
US63/089,220 2020-10-08
PCT/US2021/054190 WO2022076830A1 (en) 2020-10-08 2021-10-08 Type i crispr-associated transposase systems

Publications (3)

Publication Number Publication Date
JP2023544822A true JP2023544822A (ja) 2023-10-25
JP2023544822A5 JP2023544822A5 (https=) 2024-10-16
JPWO2022076830A5 JPWO2022076830A5 (https=) 2024-10-16

Family

ID=81126112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521484A Pending JP2023544822A (ja) 2020-10-08 2021-10-08 I型crispr関連トランスポザーゼシステム

Country Status (7)

Country Link
US (1) US20230383315A1 (https=)
EP (1) EP4204562A4 (https=)
JP (1) JP2023544822A (https=)
CN (1) CN116234918A (https=)
AU (1) AU2021356560A1 (https=)
CA (1) CA3194645A1 (https=)
WO (1) WO2022076830A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117363554B (zh) * 2023-12-08 2024-04-09 清华大学 一种工程改造的嗜盐微生物及其构建方法和应用
CN118909782B (zh) * 2024-10-10 2025-02-18 中国科学院烟台海岸带研究所 一种除异味净水藻及其净化应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200190487A1 (en) * 2018-12-17 2020-06-18 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3132197A1 (en) * 2019-03-07 2020-09-10 The Trustees Of Columbia University In The City Of New York Rna-guided dna integration using tn7-like transposons

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200190487A1 (en) * 2018-12-17 2020-06-18 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Also Published As

Publication number Publication date
CA3194645A1 (en) 2022-04-14
EP4204562A1 (en) 2023-07-05
EP4204562A4 (en) 2024-11-06
WO2022076830A1 (en) 2022-04-14
US20230383315A1 (en) 2023-11-30
CN116234918A (zh) 2023-06-06
AU2021356560A1 (en) 2023-06-08

Similar Documents

Publication Publication Date Title
EP4291202A1 (en) Nuclease-guided non-ltr retrotransposons and uses thereof
EP4061941A1 (en) Retrotransposons and use thereof
AU2020348879A1 (en) Novel type VI CRISPR enzymes and systems
KR20230149886A (ko) 재프로그램가능한 tnpb 폴리펩티드 및 이의 용도
AU2021364399A1 (en) Reprogrammable iscb nucleases and uses thereof
WO2021097118A1 (en) Small type ii cas proteins and methods of use thereof
WO2020236967A1 (en) Random crispr-cas deletion mutant
WO2022147321A1 (en) Type i-b crispr-associated transposase systems
EP4034659A2 (en) Programmable polynucleotide editors for enhanced homologous recombination
AU2020373064A1 (en) Type I-B CRISPR-associated transposase systems
WO2021041922A1 (en) Crispr-associated mu transposase systems
WO2022150651A1 (en) Dna nuclease guided transposase compositions and methods of use thereof
EP4437094A1 (en) Reprogrammable iscb nucleases and uses thereof
WO2023230483A2 (en) Engineered chimeric iscb polypeptides and uses thereof
WO2023170535A2 (en) Novel nucleic acid-guided nucleases and use thereof
EP4204559A1 (en) Nucleic acid-guided nucleases and use thereof
WO2024197008A2 (en) Nuclease-guided non-ltr retrotransposons and uses thereof
WO2021173734A1 (en) Novel type iv and type i crispr-cas systems and methods of use thereof
JP2023544822A (ja) I型crispr関連トランスポザーゼシステム
WO2024238835A2 (en) Novel crispr enzymes and systems
WO2024015920A1 (en) Hybrid crispr-cas systems and methods of use thereof
WO2024081728A2 (en) Reprogrammable tnpb polypeptides with maze domains and uses thereof
WO2024081711A2 (en) Reprogramable tnpb polypeptides and use thereof
EP4436592A1 (en) Reprogrammable isrb nucleases and uses thereof
WO2024211453A1 (en) Engineered type v cas polynucleotides with reduced immunogenicity and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251111